At a glance
- Originator Aventis
- Class Analgesics
- Mechanism of Action Neprilysin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 22 May 2002 Discontinued for Pain in USA (unspecified route)
- 22 Aug 1995 No-Development-Reported for Pain in USA (Unknown route)